Joined Bioliberty's $3.3M Series A extension as a new investor.
NOV 2026
Develops soft-robotic rehabilitation technology combining adaptive assistance and gamified exercises to support high-repetition hand and upper-extremity physical and occupational therapy, initially for post-acute care facilities
Develops soft-robotic rehabilitation technology combining adaptive assistance and gamified exercises to support high-repetition hand and upper-extremity physical and occupational therapy, initially for post-acute care facilities. The system automatically captures therapy data to help clinicians track patient progress and inform clinical decisions.